A Trial Investigating the Efficacy and Safety of Insulin Degludec/Liraglutide Injection in Subjects With Type 2 Diabetes
Clinical trial NCT06559722 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06559722
- Sponsor
- Tonghua Dongbao Pharmaceutical Co.,Ltd
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-01
- Primary completion
- 2025-10-01
- Enrollment
- 510
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.